|
|
U.S. Market for Synthetic Oligonucleotides: Establishing Differentiation for SuccessPublished by: BioInformatics, LLC Published: Apr. 1, 2004 - 183 Pages Table of ContentsSection 1. Analysis and Interpretation of Survey Results 1-1 Introduction 1-7 The U.S. Oligo Market 1-8 Types of Oligos in Use 1-9 Throughput 1-12 Prices 1-13 Growth Trends 1-15 Commercial Oligo Suppliers 1-16 Primary Suppliers 1-17 Customer Loyalty 1-18 Supplier Characteristics 1-19 Product Attributes 1-20 Satisfaction with Product Attributes 1-23 Highly Satisfied Customers by Top Suppliers 1-24 Supplier Attributes 1-25 Assessment of Supplier Attributes 1-30 Importance, Expectations and Performance for Top Suppliers 1-33 Summary 1-34 Comparison of DNA and RNA Oligo Users Section 2. Study Methodology and Demographics 2-1 Methodology 2-8 Demographics 2-9 Questionnaire Section 3. Presentation of Survey Data 3-1 Types of custom synthetic oligos used in research DNA Oligonucleotides (Respondents = 609) Uses and Applications 3-3 Ways in which DNA oligos have been purchased/obtained over the last 12 months 3-4 Research objectives for which DNA oligos are currently used 3-5 Techniques for which DNA oligos are currently and/or planned to be used Ordering Information 3-7 Percentage of DNA oligos that are from a commercial supplier, from a core facility or synthesized by researchers 3-8 For different length ranges, average number of DNA oligos ordered per month 3-10 Percent of monthly DNA oligo purchases that are in tubes vs. plates vs. other formats 3-12 Expected changes in DNA oligo purchases from commercial suppliers over the next 12 months 3-14 Reasons for any anticipated change in DNA oligo purchases from commercial suppliers 3-16 Amount typically paid per base for DNA oligos in different formats 3-18 Additional services for which researchers usually pay 3-19 Extra amount paid per DNA oligo for these services 3-20 Percent of monthly purchases of DNA oligos that require these additional services 3-21 Use of pre-made/pre-designed DNA oligos in research 3-22 Percent of orders over the last 12 months that were for custom vs. pre-made synthetic DNA oligos Commercial Suppliers 3-23 Companies from which DNA oligos are ordered 3-24 Primary suppliers of DNA oligos 3-25 Satisfaction with specific product features of primary suppliers’ DNA oligos 3-27 Overall satisfaction with the value received for the price paid for primary suppliers’ DNA oligos 3-28 Importance of specific features when considering primary suppliers’ ability to provide DNA oligos 3-30 Level of expectations for specific features when purchasing DNA oligos from primary suppliers 3-32 Primary suppliers’ performance based on experiences 3-34 Length of time using primary suppliers of DNA oligos 3-35 Changes in primary suppliers 3-37 Changes in opinion of primary suppliers 3-38 Characteristics associated with primary suppliers DNA Oligonucleotide User Demographics 3-39 Market Segment 3-40 Job Position 3-41 Areas of Research RNA Oligonucleotides (Respondents = 161) Uses and Applications 3-43 Ways in which RNA oligos have been purchased/obtained over the last 12 months 3-44 Research objectives for which RNA oligos are currently used 3-45 Techniques for which RNA oligos are currently and/or planned to be used Ordering Information 3-47 Percentage of RNA oligos that are from a commercial supplier, from a core facility or synthesized by researchers 3-48 For different length ranges, average number of RNA oligos ordered per month 3-50 Percent of monthly RNA oligo purchases that are in tubes vs. plates vs. other formats 3-52 Expected changes in RNA oligo purchases from commercial suppliers over the next 12 months 3-54 Reasons for any anticipated change in RNA oligo purchases from commercial suppliers 3-56 Amount typically paid per base for RNA oligos in different formats 3-58 Additional services for which researchers usually pay 3-59 Extra amount paid per RNA oligo for these services 3-60 Percent of monthly purchases of RNA oligos that require these additional services 3-61 Use of pre-made/pre-designed RNA oligos in research 3-62 Percent of orders over the last 12 months that were for custom vs. pre-made synthetic RNA oligos Commercial Suppliers 3-63 Companies from which RNA oligos are ordered 3-64 Primary suppliers of RNA oligos 3-65 Satisfaction with specific product features of primary suppliers’ RNA oligos 3-67 Overall satisfaction with the value received for the price paid for primary suppliers’ RNA oligos 3-68 Importance of specific features when considering primary suppliers’ ability to provide RNA oligos 3-70 Level of expectations for specific features when purchasing RNA oligos from primary suppliers 3-72 Primary suppliers’ performance based on experiences 3-74 Length of time using primary suppliers of RNA oligos 3-75 Changes in primary suppliers 3-77 Changes in opinion of primary suppliers 3-78 Characteristics associated with primary suppliers Section 4. Appendices 4-1 Insights and Perspectives 4-22 Cross-Tabulations of Survey Data 4-38 Other Publications 4-40 About BioInformatics 4-41 Our Valued Clients AbstractOligonucleotides (oligos) are a mature product category where suppliers often conclude that price-per-base is the only area in which they can establish differentiation. It is the latter stages of the product lifecycle, however, when suppliers can maximize profitability by executing strategies to build brand loyalty and avoid destructive price competition.Researchers may obtain oligos in several ways—from outside sources like commercial suppliers or core facilities, or they can synthesize the oligos themselves. A typical commercial supplier synthesizes thousands of oligos per day and allows researchers to specify the sequence of their oligos, the amount to be synthesized, the level of purification and any modifications, etc. To compete with these suppliers, many universities and research institutes have set up core facilities to offer custom oligo synthesis. Advances in technology and simplified instrument procedures, however, have resulted in more competitive prices from commercial suppliers. Another option for researchers has been to purchase synthesis equipment and make the oligos in-house, but this too often ends up being more costly. As a result, more and more scientists source their oligos from commercial suppliers—making it is increasingly critical for suppliers to differentiate their offerings. Thus, The U.S. Market for Synthetic Oligonucleotides: Establishing Differentiation for Success is based on a 27-question survey of over 750 researchers in the United States who purchase custom synthetic oligos from commercial suppliers. This report provides an individual as well as comprehensive look at the DNA and RNA oligo markets, and highlights the current and future research trends driving demand, throughput levels, preferred formats, specialty services required and prices paid. Price is just one of the features researchers consider when choosing a source for oligonculeotides. This report closely examines ten different product attributes (such as variety of formats/modifications offered, purification options available and guaranteed minimum yields) with which researchers are most, and least, satisfied and determines the overall value of each based on the prices being paid. When the price is equal, the decision to purchase one brand of oligos over another is made between only a few attributes. By identifying those attributes deemed most valued by current and potential customers, suppliers can focus their promotional efforts to show how their products may be superior to those of their competitors—enabling them to differentiate their products favorably in the minds of decision-makers. This report also looks at 12 different supplier attributes (such as accuracy of shipment, electronic ordering capabilities via supplier Web sites and oligo design expertise) with regards to importance, performance and expectations. Through a pictorial representation, this in-depth analysis will help life science executives understand the relationship between what is important and the perceived difference between performance and expectations. For example, a customer might note that “timeliness of delivery” is very important in his/her decision to purchase one oligo over another; however, when asked what else is important in that decision, the customer may also list ten other attributes that are equally important. Thus, how does timeliness of delivery actually “rank” in relation to the entire set of decision criteria? This comparison reveals those supplier attributes that are of greatest importance to researchers using oligos from commercial suppliers and details areas where suppliers (based on performance) fall above or below expectations regarding those attributes.
Taking a closer look at how these product and supplier attributes factor into the researchers decision-making process will help companies better understand what drives purchasing decisions—enabling them to better understand how to effectively market and promote their products.
|
|
|||
|
About MarketResearch.com
|
||||